Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  leukemia
Stage/Subtype:  leukemia
Trial Type:  Treatment
Treatment/Intervention:  vaccine therapy
Results 1-7 of 7 for your search:
Start Over
Vaccine Therapy and Lenalidomide in Treating Patients With B-Cell Chronic Lymphocytic Leukemia
Phase: Phase II, Phase I
Type: Treatment
Age: 18 to 75
Trial IDs: H-30087, NCI-2013-01015, RV-CLL-PI-0715, TAIL, NCT01604031
Safety Study of Gene Modified Donor T-cells Following Partially Mismatched Stem Cell Transplant
Phase: Phase II, Phase I
Type: Treatment
Age: 18 to 65
Trial IDs: BP-HM-001, NCI-2013-00518, NCT01744223
Recombinant Interferon Alpha-2a and Sargramostim or Vaccine Therapy in Treating Patients with Chronic Phase Chronic Myelogenous Leukemia Receiving Tyrosine Kinase Inhibitor Therapy
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: J05121, NCI-2011-00392, CDR0000492005, JHOC-J05121, NA_00001887, NCT00363649
Vaccine Therapy with or without Pidilizumab in Treating Patients with Acute Myeloid Leukemia in Complete Remission after Chemotherapy
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 09-412, NCI-2010-01612, NCT01096602
WT-1 Analog Peptide Vaccine in Treating Patients with Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 10-143, NCI-2011-00086, NCT01266083
Vaccine Therapy after Donor Stem Cell Transplant in Treating Patients with Advanced Myelodysplastic Syndrome or Acute Myeloid Leukemia
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 12-217, NCI-2013-00286, NCT01773395
Lenalidomide in Improving Hypogammaglobulinemia and Impaired Response to Vaccinations in Patients with Chronic Lymphocytic Leukemia
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 2013-0371, NCI-2014-01058, RV-CL-CLL-PI-002544, NCT01924169
Start Over